BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LT-010391 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of LT-010391\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07624214-2600@assetmemo.bio
DTSTAMP:20261121T005448Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:LT-010391: Phase 1 readout est. (NCT07624214)
DESCRIPTION:LT-010391\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Study
  of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors\nEstimate
 d primary completion: April 2028. This is a ClinicalTrials.gov estimate\, 
 not a confirmed readout date\, and it can move.\nDrug page: https://assetm
 emo.bio/drug/lt-010391#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT07624214
URL:https://assetmemo.bio/drug/lt-010391#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
